Atnaujinkite slapukų nuostatas

2020 Nelson's Pediatric Antimicrobial Therapy 26th Revised edition [Minkštas viršelis]

, , , , , , , ,
  • Formatas: Paperback / softback, 320 pages, aukštis x plotis: 171x121 mm, weight: 277 g
  • Išleidimo metai: 15-Jan-2020
  • Leidėjas: American Academy of Pediatrics
  • ISBN-10: 1610023528
  • ISBN-13: 9781610023528
Kitos knygos pagal šią temą:
2020 Nelson's Pediatric Antimicrobial Therapy 26th Revised editionDidesnis paveikslėlis
  • Formatas: Paperback / softback, 320 pages, aukštis x plotis: 171x121 mm, weight: 277 g
  • Išleidimo metai: 15-Jan-2020
  • Leidėjas: American Academy of Pediatrics
  • ISBN-10: 1610023528
  • ISBN-13: 9781610023528
Kitos knygos pagal šią temą:
Pastovi nuoroda: https://www.kriso.lt/db/9781610023528.html
Raktažodžiai:

The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens.



This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices.

The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices.

Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens.

New in the 26th edition:
  • First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactam
  • Replacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)
  • Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infections
  • Updates on management of influenza, including baloxavir (now approved for children >12 years)
  • New approaches to treatment of mucomycosis
  • New recommendations for malaria
  • More than 150 new references!

 

Recenzijos

2020 Nelson's Pediatric Antimicrobial Therapy has been selected as one of Doodys Core Titles®

Introduction vii
Notable Changes to 2020 Nelson's Pediatric Antimicrobial Therapy, 26th Edition xi
1 Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
1(8)
2 Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
9(10)
3 How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
19(4)
4 Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and MethiciIlin-Resistant Staphylococcus aureus
23(8)
5 Antimicrobial Therapy for Newborns
31(32)
A Recommended Therapy for Selected Newborn Conditions
33(22)
B Antimicrobial Dosages for Neonates
55(4)
C Aminoglycosides
59(1)
D Vancomycin
60(1)
E Use of Antimicrobials During Pregnancy or Breastfeeding
60(3)
6 Antimicrobial Therapy According to Clinical Syndromes
63(68)
A Skin and Soft Tissue Infections
66(6)
B Skeletal Infections
72(3)
C Eye Infections
75(4)
D Ear and Sinus Infections
79(3)
E Oropharyngeal Infections
82(3)
F Lower Respiratory Tract Infections
85(13)
G Cardiovascular Infections
98(7)
H Gastrointestinal Infections
105(7)
I Genital and Sexually Transmitted Infections
112(4)
J Central Nervous System Infections
116(5)
K Urinary Tract Infections
121(2)
L Miscellaneous Systemic Infections
123(8)
7 Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
131(28)
A Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
132(2)
B Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
134(2)
C Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
136(2)
D Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
138(21)
8 Preferred Therapy for Specific Fungal Pathogens
159(18)
A Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
160(2)
B Systemic Infections
162(14)
C Localized Mucocutaneous Infections
176(1)
9 Preferred Therapy for Specific Viral Pathogens
177(18)
A Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
178(1)
B Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
178(2)
C Preferred Therapy for Specific Viral Pathogens
180(15)
10 Preferred Therapy for Specific Parasitic Pathogens
195(24)
A Selected Common Pathogenic Parasites and Suggested Agents for Treatment
196(2)
B Preferred Therapy for Specific Parasitic Pathogens
198(21)
11 Alphabetic Listing of Antimicrobials
219(32)
A Systemic Antimicrobials With Dosage Forms and Usual Dosages
221(23)
B Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
244(7)
12 Antibiotic Therapy for Children Who Are Obese
251(4)
13 Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
255(2)
14 Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
257(18)
A Postexposure Antimicrobial Prophylaxis to Prevent Infection
259(6)
B Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
265(1)
C Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
266(3)
D Surgical/Procedure Prophylaxis
269(6)
Appendix: Nomogram for Determining Body Surface Area 275(2)
References 277(24)
Index 301